Pig kidney transplant recipient dies
Richard Slayman has passed away two months after undergoing the historic procedure
![Doctors transplanting a kidney](https://cdn.mos.cms.futurecdn.net/uKRQtLy6erNbB8v2qjzTy-415-80.jpg)
What happened
Richard "Rick" Slayman, the first patient to receive a genetically modified pig kidney, has died, his family and Boston's Massachusetts General Hospital said Sunday. Slayman, 62, underwent four hours of surgery at Mass General on March 16 and was released from the hospital in early April, no longer needing dialysis and with "one of the cleanest bills of health I've had in a long time," he said at the time.
Who said what
Mass General said it was "deeply saddened" at Slayman's "sudden passing" and has "no indication that it was the result of his recent transplant." The hospital's transplant team also thanked Slayman for his "trust and willingness to advance the field of xenotransplantation," or transplanting animal organs into humans.
What next?
Slayman's operation was a "medical milestone," showing that animal organs genetically modified to "make them more compatible with their recipients" can be successfully transplanted, at least for a short while, The New York Times said. Slayman's family said he accomplished his goal of providing "hope for the thousands of people who need a transplant to survive."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
China's pork battle with the EU
Under the Radar Beijing hits EU pork products with anti-dumping investigation while domestic market battles oversupply and falling demand
By Harriet Marsden, The Week UK Published
-
Today's political cartoons - June 23, 2024
Cartoons Sunday's cartoons - MAGA pessimism, California business, and more
By The Week US Published
-
5 fully-loaded cartoons on the bump stock ruling
Cartoons Artists take on Tommy guns, technicalities, and more
By The Week US Published
-
Gene variant shows promise slowing Alzheimer's
Speed Read A rare genetic trait called Christchurch could delay the onset of disease
By Peter Weber, The Week US Published
-
Engineered stone is bad for the lungs
Under the Radar Quartz comes at a cost
By Devika Rao, The Week US Published
-
Why are girls starting puberty earlier?
In Depth Getting older, younger
By Devika Rao, The Week US Published
-
FDA panel rejects ecstasy to treat PTSD
Speed Read It cited flawed study data and the potential for abuse
By Peter Weber, The Week US Published
-
Cannabis tops alcohol in daily US consumption
Speed Read For the first time in U.S. history, daily cannabis users have outpaced daily drinkers
By Rafi Schwartz, The Week US Published
-
US overdose deaths fell in 2023, still topped 100k
Speed Read New CDC data shows drug overdose deaths dropped for the first time in five years
By Peter Weber, The Week US Published
-
Antimicrobial resistance 'worse than climate change'
Speed Read Untreatable infections will 'make some of Covid look minor'
By The Week UK Published
-
What reclassifying cannabis could change
The Explainer The Biden administration's move to change marijuana from a Schedule I narcotic to Schedule III could reshape the pot landscape even if it doesn't mean full federal legalization
By Rafi Schwartz, The Week US Published